资产负债表（Intercept Pharmaceuticals Inc）
| 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 流动资产： | |||||||
| 现金及现金等价物(元) | 102,736,000.00 | 136,229,000.00 | 61,404,000.00 | 50,517,000.00 | 113,195,000.00 | 58,019,000.00 | 48,320,000.00 |
| 受限制存款及现金流动(元) | 920,000.00 | 1,132,000.00 | 1,620,000.00 | 5,343,000.00 | 6,981,000.00 | 7,537,000.00 | 11,153,000.00 |
| 可供出售投资流动(元) | - | - | - | - | - | 346,757,000.00 | 347,382,000.00 |
| 应收账款及票据(元) | 32,479,000.00 | 29,792,000.00 | 28,745,000.00 | 26,862,000.00 | 26,168,000.00 | 27,516,000.00 | 46,144,000.00 |
| 预付款项及其他应收款流动(元) | 27,332,000.00 | 25,986,000.00 | 26,497,000.00 | 22,356,000.00 | 21,370,000.00 | 17,307,000.00 | 24,354,000.00 |
| 短期投资(元) | 219,978,000.00 | 277,630,000.00 | 372,191,000.00 | 435,049,000.00 | 377,656,000.00 | - | - |
| 流动资产其他项目(元) | - | - | - | - | - | 29,879,000.00 | - |
| 流动资产合计(元) | 383,445,000.00 | 470,769,000.00 | 490,457,000.00 | 540,127,000.00 | 545,370,000.00 | 487,015,000.00 | 477,353,000.00 |
| 非流动资产： | |||||||
| 物业、厂房及设备(元) | 822,000.00 | 906,000.00 | 899,000.00 | 987,000.00 | 1,276,000.00 | 1,002,000.00 | 3,059,000.00 |
| 受限制存款及现金非流动(元) | 1,275,000.00 | 1,276,000.00 | 1,025,000.00 | 1,013,000.00 | 1,125,000.00 | 627,000.00 | 6,926,000.00 |
| 非流动资产其他项目(元) | 7,620,000.00 | 11,684,000.00 | 11,704,000.00 | 11,584,000.00 | 11,633,000.00 | 9,953,000.00 | 16,019,000.00 |
| 非流动资产合计(元) | 9,717,000.00 | 13,866,000.00 | 13,628,000.00 | 13,584,000.00 | 14,034,000.00 | 11,582,000.00 | 26,004,000.00 |
| 总资产(元) | 393,162,000.00 | 484,635,000.00 | 504,085,000.00 | 553,711,000.00 | 559,404,000.00 | 498,597,000.00 | 503,357,000.00 |
| 流动负债： | |||||||
| 短期债务及长期负债本期部分(元) | - | 109,808,000.00 | 109,688,000.00 | 109,569,000.00 | 109,452,000.00 | - | - |
| 应付账款及票据(元) | 89,494,000.00 | 73,682,000.00 | 95,185,000.00 | 116,977,000.00 | 109,888,000.00 | 86,364,000.00 | 147,060,000.00 |
| 其他应付款及应计费用(元) | 1,351,000.00 | 3,532,000.00 | 2,244,000.00 | 3,531,000.00 | 2,244,000.00 | 8,635,000.00 | 3,976,000.00 |
| 流动负债其他项目(元) | - | - | - | - | - | 56,428,000.00 | - |
| 流动负债合计(元) | 90,845,000.00 | 187,022,000.00 | 207,117,000.00 | 230,077,000.00 | 221,584,000.00 | 151,427,000.00 | 151,036,000.00 |
| 非流动负债： | |||||||
| 长期债务(元) | 223,856,000.00 | 223,603,000.00 | 223,352,000.00 | 223,104,000.00 | 222,856,000.00 | 717,003,000.00 | 724,082,000.00 |
| 非流动负债其他项目(元) | 6,616,000.00 | 6,464,000.00 | 6,431,000.00 | 7,453,000.00 | 7,288,000.00 | - | - |
| 非流动负债合计(元) | 230,472,000.00 | 230,067,000.00 | 229,783,000.00 | 230,557,000.00 | 230,144,000.00 | 717,003,000.00 | 724,082,000.00 |
| 总负债(元) | 321,317,000.00 | 417,089,000.00 | 436,900,000.00 | 460,634,000.00 | 451,728,000.00 | 868,430,000.00 | 875,118,000.00 |
| 股东权益： | |||||||
| 普通股(元) | 42,000.00 | 42,000.00 | 42,000.00 | 42,000.00 | 41,000.00 | 30,000.00 | 30,000.00 |
| 股本溢价(元) | 2,256,681,000.00 | 2,250,008,000.00 | 2,243,789,000.00 | 2,238,179,000.00 | 2,231,667,000.00 | 2,016,201,000.00 | 2,007,684,000.00 |
| 留存收益(元) | -2,177,675,000.00 | -2,174,885,000.00 | -2,169,023,000.00 | -2,136,888,000.00 | -2,116,063,000.00 | -2,383,516,000.00 | -2,375,988,000.00 |
| 累计其他全面收益(元) | -7,203,000.00 | -7,619,000.00 | -7,623,000.00 | -8,256,000.00 | -7,969,000.00 | -2,548,000.00 | -3,487,000.00 |
| 归属于母公司股东权益(元) | 71,845,000.00 | 67,546,000.00 | 67,185,000.00 | 93,077,000.00 | 107,676,000.00 | -369,833,000.00 | -371,761,000.00 |
| 股东权益合计(元) | 71,845,000.00 | 67,546,000.00 | 67,185,000.00 | 93,077,000.00 | 107,676,000.00 | -369,833,000.00 | -371,761,000.00 |
| 负债及股东权益合计(元) | 393,162,000.00 | 484,635,000.00 | 504,085,000.00 | 553,711,000.00 | 559,404,000.00 | 498,597,000.00 | 503,357,000.00 |
| 公告日期 | 2023-11-06 | 2023-08-02 | 2023-04-27 | 2023-03-02 | 2022-11-01 | 2022-08-03 | 2022-05-06 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||
| 核数师 |